Physician profile
Anne E Braim
NPI 1093209942
$1,377.96
in general payments reported to CMS, 2019-2025
11 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $40.92 · 2021: $189 · 2022: $188 · 2023: $271 · 2024: $237 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $622.28 | 2019-2025 | Total30, Precision7, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $254.48 | 2019-2024 | Acuvue |
| Allergan, INC. | $142.72 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $125.00 | 2021 | |
| Abbvie INC. | $123.33 | 2022 | |
| Biotissue Holdings INC. | $34.34 | 2023-2025 | |
| Oyster Point Pharma, INC. | $17.86 | 2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $17.51 | 2020 | |
| Shire North American Group INC | $17.21 | 2019 | |
| Lkc Technologies, INC. | $14.94 | 2025 | |
| Abb Con-Cise Optical Group LLC | $8.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Braim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.